Aeri stock recommendations

Aerie Pharmaceuticals, Inc. Common Stock (AERI) Analyst ... Find the latest analyst research for Aerie Pharmaceuticals, Inc. Common Stock (AERI) at Nasdaq.com. Brokerage Recommendations - Zacks Investment Research The ABR is the calculated average of the actual recommendations (strong buy, hold, sell etc) made by the brokerage firms for a given stock. ABR vs Zacks Rank Premium Research for AERI Aerie Pharmaceuticals, Inc. (AERI) Analyst Ratings ... See Aerie Pharmaceuticals, Inc. (AERI) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

Get breaking news and analysis on Aerie Pharmaceuticals, Inc. (AERI) stock, price quote and chart, trading and investing tools.

Aerie Pharmaceuticals (AERI) came out with a quarterly loss of $0.86 per share versus the Zacks Consensus Estimate of a loss of $0.84. This compares to loss of $1.73 per share a year ago. NASDAQ:AERI | Analyst Ratings

Aerie Pharmaceuticals (NASDAQ:AERI) Cut to “Hold” at Zacks ...

The 9 Best Biotech Stocks to Buy for a Blowout 2019

Analyzing Aerie Pharmaceuticals (NASDAQ:AERI) stock? View AERI's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock …

The average rating presented in the last row of the above table above is from 1 to 5 where 1 is Strong Buy and 5 is Strong Sell. For the AERI price target at the top of this page, we present the average AERI target price across the 12 analysts covering AERI, as reported in … AERI Stock Price & Charts | Aerie Pharmaceuticals In depth view into AERI (Aerie Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. Investors Catching Stocks Watsco, Inc.(NYSE:WSO): Aerie ... Mar 12, 2020 · The Stock currently has a Weekly Volatility of 8.47% and Monthly Volatility of 4.01%. Aerie Pharmaceuticals, Inc. (AERI) will report its next earnings on Feb 20 AMC. Aerie Pharmaceuticals (NASDAQ:AERI) Cut to “Hold” at Zacks ... Zacks Investment Research cut shares of Aerie Pharmaceuticals (NASDAQ:AERI) from a buy rating to a hold rating in a research note published on Monday morning, Zacks.com reports. The brokerage

Mar 12, 2020 · The Stock currently has a Weekly Volatility of 8.47% and Monthly Volatility of 4.01%. Aerie Pharmaceuticals, Inc. (AERI) will report its next earnings on Feb 20 AMC.

AERI Stock Price, Forecast & News (Aerie Pharmaceuticals) Analyzing Aerie Pharmaceuticals (NASDAQ:AERI) stock? View AERI's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock …